BIA
PGEN icon

Biondo Investment Advisors’s Precigen PGEN Stock Holding History

Biondo Investment Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,700
Closed -$214K – 88
2017
Q1 		$214K Buy
+8,700
New +$194K 0.08% 73
2016
Q4 		– Sell
-8,778
Closed -$244K – 78
2016
Q3 		$244K Hold
8,778
– – 0.08% 70
2016
Q2 		$214K Sell
8,778
-4,743
-35% -$135K 0.08% 72
2016
Q1 		$454K Sell
13,521
-22,879
-63% -$720K 0.17% 62
2015
Q4 		$1.09M Sell
36,400
-2,522
-6% -$85K 0.36% 50
2015
Q3 		$1.23M Buy
38,922
+21,618
+125% +$1.05M 0.41% 51
2015
Q2 		$837K Buy
17,304
+4,670
+37% +$197K 0.25% 53
2015
Q1 		$548K Buy
+12,634
New +$454K 0.16% 60

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Biondo Investment Advisors's PGEN Position: Q2 2017 in Review

Biondo Investment Advisors sold out of Precigen (PGEN) in Q2 2017, closing a stake of 8,700 shares — an estimated $214K sold.

Biondo Investment Advisors first reported a position in PGEN in Q1 2015 and held it in 8 quarters. The position peaked at $1.23M in Q3 2015. 172 funds tracked by Wall St. Rank hold PGEN as of Q2 2017.

  • Biondo Investment Advisors reported no remaining Precigen position as of Q2 2017 after selling out during the quarter.
  • Biondo Investment Advisors sold 8,700 Precigen shares in Q2 2017, an estimated $214K.
  • Biondo Investment Advisors first reported a position in Precigen in Q1 2015 and held it in 8 quarters.
  • Biondo Investment Advisors's Precigen position peaked at $1.23M in Q3 2015.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q2 2017.

Based on Biondo Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.